Venetoclax-ponatinib for T315I/compound-mutated Ph plus acute lymphoblastic leukemia

Wang, HF; Yang, C; Shi, T; Zhang, Y; Qian, JJ; Wang, YG; Hu, YX; Mao, LP; Ye, XJ; Liu, F; Xi, ZF; Shou, LH; Fu, CY; Naranmandura, H; Jin, J; Zhu, HH

Naranmandura, H; Jin, J; Zhu, HH (通讯作者),Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Sch Med, Hangzhou, Peoples R China.;Jin, J; Zhu, HH (通讯作者),Zhejiang Univ, Zhejiang Prov Key Lab Hematopoiet Malignancy, Hangzhou, Zhejiang, Peoples R China.;Jin, J; Zhu, HH (通讯作者),Zhejiang Univ, Inst Hematol, Hangzhou, Zhejiang, Peoples R China.;Jin, J; Zhu, HH (通讯作者),Zhejiang Univ, Canc Ctr, Hangzhou, Zhejiang, Peoples R China.;Naranmandura, H (通讯作者),Zhejiang Univ, Dept Publ Hlth, Sch Med, Hangzhou, Peoples

BLOOD CANCER JOURNAL, 2022; 12 (1):